Reducing Animal Testing via Modeling
New AI Chair to Lead Drug Discovery Research
Dr. Amber Simpson joins University of Alberta to reduce animal testing through computational drug modeling.
A researcher studies a digital molecular structure on a large screen in a bright, modern laboratory setting.
Photo: Avantgarde News
Dr. Amber Simpson has been appointed as a Canada CIFAR AI Chair at the University of Alberta [1]. Her work focuses on biomedical computing and artificial intelligence to advance precision diagnostics [1][2]. This role aims to revolutionize drug development by applying advanced computational models [1].
Simpson's research specifically targets reducing scientific reliance on animal testing [1]. By using digital drug modeling, the team hopes to provide more efficient alternatives to traditional testing methods [1]. She also holds a position with the Alberta Machine Intelligence Institute [2].
Editorial notes
Transparency note
AI assisted drafting. Human edited and reviewed.
- AI assisted
- Yes
- Human review
- Yes
- Last updated
Risk assessment
The source material includes only two independent domains (University of Alberta and Amii), which fails the internal requirement for at least three independent sources.
Sources
Related stories
View all
Topics
About the author
Avantgarde News Desk covers reducing animal testing via modeling and editorial analysis for Avantgarde News.